Daclangin, Baby Girl .
HRN: 26-58-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2025
AMPICILLIN 500MG (VIAL)
01/26/2025
02/01/2025
IVT
200mg
Q12
Sepsis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes